NL-OMON52088招募中不适用
A nationwide natural history study in Becker muscular dystrophy: Modeling a slowly progressive neuromuscular disease to prepare for clinical trials. - Natural history BMD 2022
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •BMD patient cohort:
- •Confirmation of diagnosis of BMD by DNA analysis
- •Age >=5 years
- •In order to be eligible to partake in the muscle biopsy part of this study, the
- •following additional inclusion criteria apply:
- •Age >= 18 years
- •BMD trial participants cohort:
- •Confirmation of diagnosis of BMD by DNA analysis
- •Age >=5 years
- •Inclusion in the phase II study of EDG-5506 in BMD (P22-064)
- •Healthy controls:
- •Age >=5 years
- •In order to be eligible to partake in the muscle biopsy part of this study, the
- •following additional inclusion criteria apply:
- •Age >= 18 years
排除标准
- •Patients will not undergo MRI or muscle biopsy if they have contraindication
- •for the MRI (such as a metal implant) or muscle biopsy (such as use of
- •anticoagulation) respectively. If this is the case, it is still possible to
- •partake in the other parts of this study.
研究者
相似试验
已完成
Unknown
RETROSPECTIVE COHORT STUDY OF THE NATURAL HISTORY OF TYPE 1 SPINAL MUSCULAR ATROPHY USING MEDICAL RECORD DATASpinal Muscular AtrophyJPRN-jRCT1080224067F. Hoffmann-La Roche, Ltd., Chugai Pharmaceutical160
招募中
不适用
The natural history study of Becker muscular dystrophyBecker muscular dystrophy / BMD10029317NL-OMON46870eids Universitair Medisch Centrum50
招募中
不适用
Studying the consequences of Chikungunya and increasing the peoples’ quality of lifeArbovirusesQuality of lifeC02.782.930.100.184Muskuloskeletal abnormalitiesChikungunya FeverB04.080I01.800C05.660RBR-3qg2myInstituto Nacional de Infectologia Evandro Chagas/Fundacao Oswaldo Cruz (INI/Fiocruz)
尚未招募
不适用
A Prospective Natural History Study of the Progression of Physical Impairment, Activity Limitation and Quality of Life in Duchenne Muscular Dystrophy (DMD)Duchenne Muscular Dystrophy (DMD)muscular dystrophy1002839610028302NL-OMON39538Prosensa Therapeutics B.V.30
尚未招募
不适用
Studying the progression and the consequences of the new Coronavirus in BrazilCoronavirus disease 2019BetacoronavirusSevere acute respiratory syndromeC01.925.782.600.550.200C01.748.730C01.748.610B04.820.504.540.150.113PneumoniaRBR-8hmb2rInstituto Nacional de Infectologia Evandro Chagas/Fundacao Oswaldo Cruz (INI/Fiocruz)